Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,650,626 papers from all fields of science
Search
Sign In
Create Free Account
Diflucortolone
Known as:
Difluocortolone
, 6Alpha,9-Difluoro-11Beta,21-Dihydroxy-16Alpha-Methylpregna-1,4-Diene-3,20-Dione
, Diflucortolone [Chemical/Ingredient]
Expand
A topical glucocorticoid used in various DERMATOSES. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Broader (2)
Anti-Inflammatory Agents
Glucocorticoids
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Narrower (3)
Neriproct
Travocort
diflucortolone valerate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Topical Mometasone
A. Prakash
,
P. Benfield
Drugs
2012
Corpus ID: 46976211
SummarySynopsisMometasone, a synthetic 16α-methyl analogue of beclomethasone, is classified as a ‘potent’ glucocorticoid for…
Expand
2012
2012
Diflucortolone Valerate Asian Experience
G. Hoppe
Drugs
2012
Corpus ID: 36720839
SummaryMore than 10 years ago, diflucortolone valerate (Nerisone®, Nerisona®) was introduced in Germany and soon after in Asian…
Expand
2004
2004
Effect of a topical steroid on gene expressions for chemokines in mice with contact hypersensitivity.
Gaku Mitsui
,
Takeo Hirano
,
+4 authors
Masatoshi Kato
International Immunopharmacology
2004
Corpus ID: 9257811
1997
1997
Topical glucocorticoid augments IgE‐mediated passive cutaneous anaphylaxis in Balb/C mice and mast cell deficient WBB6F1 v/v mice
I. Katayama
,
K. Igawa
,
K. Minatohara
,
K. Nishioka
Clinical and Experimental Allergy
1997
Corpus ID: 6693202
Background In a last decade, new types of skin manifestations have been recognized in atopic dermatitis especially in Japan. They…
Expand
1993
1993
Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
A. Kecskés
,
P. Jahn
,
H. Wendt
,
R. Kleine-Kuhlmann
,
L. Lange
Arzneimittel-Forschung
1993
Corpus ID: 9540541
Topical glucocorticosteroids are useful in the treatment of various skin diseases. Although there are already many…
Expand
1993
1993
Does salicylic acid increase the percutaneous absorption of diflucortolone-21-valerate?
U. Täuber
,
C. Weiss
,
H. Matthes
Skin Pharmacology
1993
Corpus ID: 1259119
The percutaneous absorption of diflucortolone-21-valerate (DFV) and its effect on the pituitary adrenal system were investigated…
Expand
1983
1983
A comparative multicentre trial of halometasone/triclosan cream and diflucortolone valerate/chlorquinaldol cream in the treatment of acute dermatomycoses.
E. Maeder
,
C. Schindléry
,
V. Macarol
,
P. Schoenenberger
Journal of International Medical Research
1983
Corpus ID: 22316405
In this multicentre, between-patient trial the efficacy and tolerability of a cream, containing 0.05% halometasone and 1…
Expand
1978
1978
Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
G. L. Coleman
,
I. Kanfer
,
J. Haigh
Dermatologica
1978
Corpus ID: 11489212
The blanching activities and hence bioavailabilities of the cream, ointment and fatty ointment preparations of Nerisone and…
Expand
1978
1978
Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients
K. Keczkes
,
P. Teasdale
,
R. Wiseman
,
C. Mugglestone
British Journal of Dermatology
1978
Corpus ID: 45321209
A double‐blind randomized study to compare the plasma cortisol values at both 9.00 a.m. and 12 midnight following topical…
Expand
1968
1968
The assessment o2 four new fluocortolone analogues by a modified vasoconstriction assay.
H. Baker
,
H. Sattar
British Journal of Dermatology
1968
Corpus ID: 19736319
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE